25 results on '"Leon, Kalet"'
Search Results
2. Unraveling a Conserved Conformation of the FG Loop upon the Binding of Natural Ligands to the Human and Murine PD1
3. Treatment of Systemic Inflammation with Itolizumab: A Single Center Experience
4. Deciphering PD1 activation mechanism from molecular docking and molecular dynamic simulations
5. Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
6. Differential Effects of IL2Rα and IL15Rα over the Stability of the Common Beta-Gamma Signaling Subunits of the IL2 and IL15 Receptors
7. An Anti-CD6 Antibody for the Treatment of COVID-19 Patients with Cytokine-Release Syndrome: Report of Three Cases
8. Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19
9. In-silico media optimization for continuous cultures using genome scale metabolic networks: the case of CHO-K1
10. Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19
11. Modulation of CD4 T cell function via CD6-targeting
12. Abstract CT088: Final results of the Phase I study of nivolumab in combination with CIMAvax, an epidermal growth factor(EGF)-depleting immunotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Focus on biomarker analyses
13. Abstract CT088: Final results of the Phase I study of nivolumab in combination with CIMAvax, an epidermal growth factor(EGF)-depleting immunotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Focus on biomarker analyses
14. Characterizing steady states of genome-scale metabolic networks in continuous cell cultures
15. Abstract B120: Synergistic potentiation of the anti-metastatic effect of anti EGFR mAbs by its combination with immunotherapies targeting the ganglioside NGcGM3
16. Abstract B011: Human IL-2 mutant exhibits a higher antitumor efficacy and lower toxicity than wildtype IL-2 in different preclinical contexts
17. Molecular dissection of the interactions of an antitumor interleukin-2-derived mutein on a phage display-based platform
18. Computational proteomics pitfalls and challenges: HavanaBioinfo 2012 Workshop report
19. Deciphering the molecular bases of the biological effects of antibodies against Interleukin-2: A versatile platform for fine epitope mapping
20. Preclinical Efficacy of Nimotuzumab, an Anti-Egfr Monoclonal Antibody as a Single Agent Therapy in Human GBM u87mg Xenografts
21. Therapeutic Approaches to Target Cancer Stem Cells
22. How Regulatory CD25+CD4+ T Cells Impinge on Tumor Immunobiology: The Differential Response of Tumors to Therapies
23. How regulatory CD25+CD4+T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors
24. When three is not a crowd: a Crossregulation Model of the dynamics and repertoire selection of regulatory CD4+T cells
25. Immunological self-tolerance: Lessons from mathematical modeling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.